IP Library Granted Patent US 10,426,955
Granted Patent B2
US 10,426,955 · App. 15/332,861 · Granted Oct 1, 2019

Methods for implanting electrodes and treating a patient with gastreosophageal reflux disease

Inventors: Virender K. Sharma (Paradise Valley, AZ); Matt Joseph Gani (Seattle, WA); Paul V. Goode (Round Rock, TX); Bevil Hogg (Murrieta, CA); Jay Miazga (Seattle, WA); Shai Policker (Tenafly, NJ); Kaila Raby (Albuquerque, NM)
Assignee: EndoStim, Inc.
A61N1/36007A61B5/0031A61B5/42A61B5/687A61B5/6852A61B5/6861A61N1/0507A61N1/0517A61N1/3606A61N1/36017A61N1/36021A61N1/36125A61N1/36139A61N1/36146A61N1/36157A61N1/36171A61N1/36175A61N1/37264A61B5/4836
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,955
App. No.
15/332,861
Granted
Oct 1, 2019
Kind
B2
Abstract

The present specification discloses devices and methodologies for the treatment of transient lower esophageal sphincter relaxations (tLESRs). Individuals with tLESRs may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow and have improved energy storage requirements.

Claims (18)

1. A method of implanting electrodes in a patient in order to treat gastroesophageal reflux disease, comprising:

implanting a first electrode in a stomach of the patient;

implanting a second electrode in the stomach of the patient, wherein the second electrode is positioned parallel to the first electrode;

connecting the first electrode and the second electrode to a pulse stimulator configured to supply a stimulation pulse to the first electrode and the second electrode;

programming the pulse stimulator to apply a train of stimulation pulses, wherein the pulse stimulator is not in data communication with an implanted sensor configured to sense a physiological state of the patient; and

operating the first electrode and the second electrode in combination to deliver the stimulation pulses to normalize a function of a lower esophageal sphincter (LES) of the patient post-stimulation.

2. The method of claim 1 , wherein the stimulation pulses have a pulse amplitude equal to or less than 15 mAmp.

3. The method of claim 1 , wherein the second electrode is separated from the first electrode by a distance equal to or less than 1.5 cm.

4. The method of claim 1 , wherein the first electrode and the second electrode are each positioned more than 1 mm away from a vagal trunk of the patient.

5. A method of implanting a first electrode and a second electrode in a patient in order to treat gastroesophageal reflux disease, comprising:

implanting the first electrode in a stomach of the patient;

implanting the second electrode in a stomach of the patient, wherein the second electrode is positioned skew relative to the first electrode,

connecting the first electrode and the second electrode to a pulse stimulator configured to supply a stimulation pulse to the first electrode and the second electrode;

programming the pulse stimulator to apply a train of stimulation pulses, wherein the pulse stimulator is not in data communication with an implanted sensor configured to sense a physiological state of the patient; and

operating the first electrode and the second electrode in combination to deliver the stimulation pulses to normalize a function of a lower esophageal sphincter (LES) of the patient post-stimulation.

6. The method of claim 5 , wherein the stimulation pulses have a pulse amplitude equal to or less than 15 mAmp.

7. The method of claim 5 , wherein the second electrode is separated from the first electrode by a distance equal to or less than 1.5 cm.

8. The method of claim 5 , wherein each of the first electrode and the second electrodes is positioned more than 1 mm away from a vagal trunk of said patient.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2022
From: ENDOSTIM (ABC), LLC
To: PARAS HOLDINGS, LLC
Reel/Frame 060616/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: ENDOSTIM, INC.
To: ENDOSTIM (ABC), LLC
Reel/Frame 056030/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2016
From: SHARMA, VIRENDER K.; GANI, MATT JOSEPH; GOODE, PAUL V.; HOGG, BEVIL; MIAZGA, JAY; POLICKER, SHAI; RABY, KAILA
To: ENDOSTIM, INC.
Reel/Frame 040106/0176 →
Continuity (20)
Continuation 14695267 · Apr 24, 2015
Continuation 14201766 · Mar 7, 2014
Continuation In Part 14175927 · Feb 7, 2014
Continuation In Part 13661483 · Oct 26, 2012
Continuation 12775436 · May 6, 2010
Continuation 11539645 · Oct 9, 2006
Continuation In Part 13041063 · Mar 4, 2011
Continuation In Part 13041114 · Mar 4, 2011
Continuation In Part 13934040 · Jul 2, 2013
Continuation 12359317 · Jan 25, 2009
Provisional Application 61444489 · Feb 21, 2011
Provisional Application 61422967 · Dec 14, 2010
Provisional Application 61414378 · Nov 16, 2010
Provisional Application 61384105 · Sep 17, 2010
Provisional Application 61371146 · Aug 5, 2010
Provisional Application 61328702 · Apr 28, 2010
Provisional Application 61318843 · Mar 30, 2010
Provisional Application 61310755 · Mar 5, 2010
Provisional Application 61023535 · Jan 25, 2008
Related Publication 20170036021A1 · Feb 9, 2017
Cited By (1)
US 12,233,254